172 related articles for article (PubMed ID: 3348612)
1. Multiple-dose pharmacokinetics and toleration of intravenously administered cefoperazone and sulbactam when given as single agents or in combination.
Reitberg DP; Whall TJ; Chung M; Blickens D; Swarz H; Arnold J
Antimicrob Agents Chemother; 1988 Jan; 32(1):42-6. PubMed ID: 3348612
[TBL] [Abstract][Full Text] [Related]
2. Multiple-dose pharmacokinetics of intravenously administered cefoperazone and sulbactam when given in combination to infected, seriously ill, elderly patients.
Schwartz JI; Jauregui LE; Bachmann KA; Martin ME; Reitberg DP
Antimicrob Agents Chemother; 1988 May; 32(5):730-5. PubMed ID: 3395103
[TBL] [Abstract][Full Text] [Related]
3. Steady-state pharmacokinetics of cefoperazone and sulbactam in patients with acute appendicitis.
Danziger LH; Piscitelli SC; Occhipinti DJ; Resnick DJ; Rodvold KA
Ann Pharmacother; 1994 Jun; 28(6):703-7. PubMed ID: 7919553
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics and pharmacodynamics of cefoperazone-sulbactam in patients on continuous ambulatory peritoneal dialysis.
Johnson CA; Zimmerman SW; Reitberg DP; Whall TJ; Leggett JE; Craig WA
Antimicrob Agents Chemother; 1988 Jan; 32(1):51-6. PubMed ID: 3348613
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetics of cefoperazone (2.0 g) and sulbactam (1.0 g) coadministered to subjects with normal renal function, patients with decreased renal function, and patients with end-stage renal disease on hemodialysis.
Reitberg DP; Marble DA; Schultz RW; Whall TJ; Schentag JJ
Antimicrob Agents Chemother; 1988 Apr; 32(4):503-9. PubMed ID: 3377461
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics of cefoperazone and sulbactam in liver transplant patients.
Muder RR; Agarwala S; Mirani A; Gayowski T; Venkataramanan R
J Clin Pharmacol; 2002 Jun; 42(6):644-50. PubMed ID: 12043952
[TBL] [Abstract][Full Text] [Related]
7. Effect of impaired renal function on the pharmacokinetics of coadministered cefoperazone and sulbactam.
Rho JP; Castle S; Smith K; Bawdon RE; Norman DC
J Antimicrob Chemother; 1992 Jun; 29(6):701-9. PubMed ID: 1506350
[TBL] [Abstract][Full Text] [Related]
8. Bioequivalence study of the two 1.5 g cefoperazone and sulbactam IM injections in Thai healthy male volunteers.
Kaewvichit S; Yotsawimonwat S; Taesotikul W; Niwatananun W; Duangrat C; Wongsinsup C; Thongsawat S; Salee P
J Med Assoc Thai; 2008 Nov; 91(11):1760-4. PubMed ID: 19127801
[TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of cefoperazone/sulbactam in critically ill patients receiving continuous venovenous hemofiltration.
Gao C; Tong J; Yu K; Sun Z; An R; Du Z
Eur J Clin Pharmacol; 2016 Jul; 72(7):823-30. PubMed ID: 27023465
[TBL] [Abstract][Full Text] [Related]
10. [Laboratory and clinical study of sulbactam/cefoperazone (SBT/CPZ) on bacterial prostatitis].
Suzuki K; Horiba M
Hinyokika Kiyo; 1991 Oct; 37(10):1333-43. PubMed ID: 1755429
[TBL] [Abstract][Full Text] [Related]
11. [Clinical evaluation of sulbactam/cefoperazone in lower respiratory tract infections].
Ishibashi T; Takamoto M; Shinoda A; Yoshida M; Ichikawa Y; Kido M; Ninomiya K; Kitahara Y; Hara N; Tsurutani H
Jpn J Antibiot; 1990 Feb; 43(2):239-56. PubMed ID: 2194054
[TBL] [Abstract][Full Text] [Related]
12. Drug concentrations in the serum and cerebrospinal fluid of patients treated with cefoperazone/sulbactam after craniotomy.
Wang Q; Wu Y; Chen B; Zhou J
BMC Anesthesiol; 2015; 15():33. PubMed ID: 25798070
[TBL] [Abstract][Full Text] [Related]
13. [Experimental study on concentrations and pharmacokinetics of antibiotics in bile and evaluation of their microbicidal potential].
Zheng J; Liang L; Wang Z; Peng B; Li S; Lai J
Zhonghua Wai Ke Za Zhi; 2014 Oct; 52(10):775-80. PubMed ID: 25573219
[TBL] [Abstract][Full Text] [Related]
14. [Transfer of injected sulbactam/cefoperazone into burn blister fluid].
Aoyama H; Sugiyama H; Tada M; Okuda J; Izawa Y
Jpn J Antibiot; 1988 Sep; 41(9):1279-84. PubMed ID: 3241326
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of cefoperazone/sulbactam in plasma and cerebrospinal fluid in patients with intraventricular hemorrhage after external ventricular drains.
Meng L; Kong L; Wu C; Qi B; Wu X
Eur J Clin Pharmacol; 2020 Jan; 76(1):127-129. PubMed ID: 31642959
[No Abstract] [Full Text] [Related]
16. Pharmacokinetics of ampicillin (2.0 grams) and sulbactam (1.0 gram) coadministered to subjects with normal and abnormal renal function and with end-stage renal disease on hemodialysis.
Blum RA; Kohli RK; Harrison NJ; Schentag JJ
Antimicrob Agents Chemother; 1989 Sep; 33(9):1470-6. PubMed ID: 2817847
[TBL] [Abstract][Full Text] [Related]
17. [Clinical laboratory approach for estimating effective administrative dose of sulbactam/cefoperazone].
Uete T; Matsuo K
Jpn J Antibiot; 1988 Nov; 41(11):1578-90. PubMed ID: 3210296
[TBL] [Abstract][Full Text] [Related]
18. Comparison of cefoperazone plus sulbactam with clindamycin plus gentamicin as treatment for intra-abdominal infections.
Greenberg RN; Cayavec P; Danko LS; Bowen K; Montazemi R; Kearney PA; Johnson SB; Strodel WE
J Antimicrob Chemother; 1994 Sep; 34(3):391-401. PubMed ID: 7829413
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics of sulbactam in humans.
Foulds G; Stankewich JP; Marshall DC; O'Brien MM; Hayes SL; Weidler DJ; McMahon FG
Antimicrob Agents Chemother; 1983 May; 23(5):692-9. PubMed ID: 6307133
[TBL] [Abstract][Full Text] [Related]
20. [Cefoperazone/sulbactam in continuous infusion].
Woźnica R; Ferenc K; Kurec D
Anestezjol Intens Ter; 2010; 42(2):80-4. PubMed ID: 21413432
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
